114 related articles for article (PubMed ID: 17726263)
21. Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAIL-induced apoptosis.
Clarke P; Tyler KL
Apoptosis; 2007 Jan; 12(1):211-23. PubMed ID: 17136319
[TBL] [Abstract][Full Text] [Related]
22. Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis.
Brooks AD; Sayers TJ
Cancer Immunol Immunother; 2005 May; 54(5):499-505. PubMed ID: 15614529
[TBL] [Abstract][Full Text] [Related]
23. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.
Kreuz S; Siegmund D; Scheurich P; Wajant H
Mol Cell Biol; 2001 Jun; 21(12):3964-73. PubMed ID: 11359904
[TBL] [Abstract][Full Text] [Related]
24. CRISPR screens identify novel regulators of cFLIP dependency and ligand-independent, TRAIL-R1-mediated cell death.
Kuehnle N; Osborne SM; Liang Z; Manzano M; Gottwein E
Cell Death Differ; 2023 May; 30(5):1221-1234. PubMed ID: 36801923
[TBL] [Abstract][Full Text] [Related]
25. RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.
Zhang L; Blackwell K; Workman LM; Chen S; Pope MR; Janz S; Habelhah H
Mol Cell Biol; 2015 Oct; 35(19):3324-38. PubMed ID: 26195820
[TBL] [Abstract][Full Text] [Related]
26. Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis.
Siegmund D; Hadwiger P; Pfizenmaier K; Vornlocher HP; Wajant H
Mol Med; 2002 Nov; 8(11):725-32. PubMed ID: 12520089
[TBL] [Abstract][Full Text] [Related]
27. Regulation of TRAIL receptor expression by β-catenin in colorectal tumours.
Jalving M; Heijink DM; Koornstra JJ; Boersma-van Ek W; Zwart N; Wesseling J; Sluiter WJ; de Vries EG; Kleibeuker JH; de Jong S
Carcinogenesis; 2014 May; 35(5):1092-9. PubMed ID: 24379239
[TBL] [Abstract][Full Text] [Related]
28. Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL.
French R; Hayward O; Jones S; Yang W; Clarkson R
Mol Cancer; 2015 Dec; 14():209. PubMed ID: 26667821
[TBL] [Abstract][Full Text] [Related]
29. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
[TBL] [Abstract][Full Text] [Related]
30. Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation.
Rijcken FE; Hollema H; Kleibeuker JH
Gut; 2002 Mar; 50(3):382-6. PubMed ID: 11839719
[TBL] [Abstract][Full Text] [Related]
31. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.
de Hooge AS; Berghuis D; Santos SJ; Mooiman E; Romeo S; Kummer JA; Egeler RM; van Tol MJ; Melief CJ; Hogendoorn PC; Lankester AC
Clin Cancer Res; 2007 Jan; 13(1):206-14. PubMed ID: 17200356
[TBL] [Abstract][Full Text] [Related]
32. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
[TBL] [Abstract][Full Text] [Related]
33. Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas.
Koornstra JJ; Kleibeuker JH; van Geelen CM; Rijcken FE; Hollema H; de Vries EG; de Jong S
J Pathol; 2003 Jul; 200(3):327-35. PubMed ID: 12845629
[TBL] [Abstract][Full Text] [Related]
34. Type I interferons induce apoptosis by balancing cFLIP and caspase-8 independent of death ligands.
Apelbaum A; Yarden G; Warszawski S; Harari D; Schreiber G
Mol Cell Biol; 2013 Feb; 33(4):800-14. PubMed ID: 23230268
[TBL] [Abstract][Full Text] [Related]
35. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation.
Kang YC; Kim KM; Lee KS; Namkoong S; Lee SJ; Han JA; Jeoung D; Ha KS; Kwon YG; Kim YM
Cell Death Differ; 2004 Dec; 11(12):1287-98. PubMed ID: 15297884
[TBL] [Abstract][Full Text] [Related]
36. Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover.
Kim JH; Kim MJ; Choi KC; Son J
Int J Biochem Cell Biol; 2016 Sep; 78():327-334. PubMed ID: 27477310
[TBL] [Abstract][Full Text] [Related]
37. TRAIL induces apoptosis in human colorectal adenoma cell lines and human colorectal adenomas.
Jalving M; de Jong S; Koornstra JJ; Boersma-van Ek W; Zwart N; Wesseling J; de Vries EG; Kleibeuker JH
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4350-6. PubMed ID: 16857810
[TBL] [Abstract][Full Text] [Related]
38. Dexamethasone protects primary cultured hepatocytes from death receptor-mediated apoptosis by upregulation of cFLIP.
Oh HY; Namkoong S; Lee SJ; Por E; Kim CK; Billiar TR; Han JA; Ha KS; Chung HT; Kwon YG; Lee H; Kim YM
Cell Death Differ; 2006 Mar; 13(3):512-23. PubMed ID: 16167066
[TBL] [Abstract][Full Text] [Related]
39. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer.
Lindgren G; Liljegren A; Jaramillo E; Rubio C; Lindblom A
Gut; 2002 Feb; 50(2):228-34. PubMed ID: 11788565
[TBL] [Abstract][Full Text] [Related]
40. TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.
Heijink DM; Jalving M; Oosterhuis D; Sloots IA; Koster R; Hollema H; Kleibeuker JH; Koornstra JJ; de Vries EG; de Jong S
J Pathol; 2011 Feb; 223(3):378-89. PubMed ID: 21171083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
